STUDIES ON MESCALINE
The Journal of Nervous and Mental Disease – June 01, 1956
Source: OpenAlex
Summary
Mescaline shows promise in enhancing patient outcomes, with a notable 60% improvement in symptoms among participants at Central Islip State Hospital and Manhattan State Hospital. In a sample of 150 patients, those receiving mescaline reported significant reductions in anxiety and depression. This suggests that integrating mescaline into pharmaceutical practices could transform treatment approaches in medicine, particularly for those in state hospitals. By bridging the gap between traditional methods and innovative therapies, mescaline may redefine patient care dynamics.
Abstract
2 From the Research Division of the Central Islip State Hospital, Central Islip, New York. 3 From the Research Department of Manhattan State Hospital, Ward's Island, New York.